WANT TO JOIN THE FIRST GLOBAL REGENERATIVE SAFETY IRB? CALL US: (844) 438-7836
  • Follow US :
Facebook-square Linkedin
Get in Touch

Provider PARTICIPATION

For Providers

Join the World's First IRB-Approved Observational Safety Database for Regenerative Therapies

R3 Stem Cell Research gives regenerative medicine practices a structured, IRB-approved framework for informed consent, patient follow-up, and adverse event monitoring — built to strengthen your documentation without changing how you treat patients.
  • Protect your practice
  • Support your patients
  • Prove your credibility — without adding to your workload.

Protocol R3-GOSD-001

IRB-approved

Multi-site

International

Why Providers Partner With R3

Regulatory expectations around informed consent and adverse event tracking for regenerative therapies are rising across states and internationally. Most practices don’t have the staff, systems, or time to build a compliant monitoring infrastructure on their own. R3 provides it — so your practice can focus on patient care while building a defensible documentation record.
  • Structured, IRB-approved consent and follow-up forms, prepared and provided by our research team.
  • Ongoing patient check-ins on a regular, structured schedule, handled by R3.
  • Rapid adverse event tracking and notification back to your practice.
  • De-identified data contribution to a multi-site observational registry, with the option to co-author findings for peer-reviewed publication.
  • Your clinical procedures and patient pricing remain entirely unchanged — patients continue to receive care as usual, out of pocket.

What Is the GOSD Registry?

The Global Observational Safety Database (Protocol R3-GOSD-001) is an IRB-approved, multi-site, international observational study built specifically for regenerative medicine. It is not a clinical trial and does not change how you treat patients — it is a monitoring and documentation layer that sits alongside your existing practice, giving you a structured way to record outcomes and respond quickly if a safety concern arises.

 

 
For practices in states with statutory IRB or safety-monitoring requirements for regenerative or biologic procedures — including Alabama, Texas, and North Carolina — GOSD provides an existing IRB-International-overseen pathway rather than requiring you to build one from scratch.

INTERESTED IN PARTICIPATING?​

Contact R3 Stem Cell Research today to learn more about our current studies and find out if your practice qualifies to participate.
Get in Touch

How Provider Participation Works

Regenerative medicine is still a young field, and its credibility will be built by the quality of the evidence behind it. R3 Stem Cell Research exists to generate that evidence — through rigorous, IRB-approved studies, global collaboration, and a genuine commitment to pushing regenerative therapies toward their next frontier.

Practice Evaluation

R3's research team reviews your practice to confirm fit and eligibility for the registry.

Onboarding

Your practice signs a Business Associate Agreement and receives IRB-approved consent and enrollment materials.

Structured Follow-Up

R3 manages scheduled patient check-ins and outcome tracking on your behalf.

Adverse Event Monitoring

Any reported concern is tracked and communicated back to your practice promptly, in line with IRB reporting requirements.

What R3 Provides

  • IRB oversight through IRB International, covering the observational protocol at every participating site.
  • Approved consent, enrollment, and follow-up documentation — no need to draft your own.
  • A signed Business Associate Agreement (BAA) covering the handling of patient health information.
  • Ongoing, structured patient check-ins that reduce the administrative load on your staff.
  • Access to a growing library of peer-reviewed publications your practice's de-identified data may help support.

Who Should Apply

R3 works with regenerative medicine practices — orthopedic, sports medicine, functional medicine, aesthetics, and related specialties — that are currently offering regenerative procedures and want a structured, third-party-overseen way to document patient outcomes and safety. Practices in states with statutory IRB or safety-reporting mandates for these procedures are especially encouraged to apply.

Get Started

Participation begins with a brief practice evaluation call with our research team. There’s no cost to apply, and clinical procedures and pricing at your practice are never affected.
Scroll to Top